New Study Reveals Hidden Side Effects of Weight-Loss Drugs
A recent study has uncovered potential side effects of GLP-1 drugs, such as Wegovy and Mounjaro, that have not been widely recognized in official research. These medications, commonly used for weight loss and diabetes management, may be causing issues like irregular periods and fever-like chills, according to an analysis of over 400,000 online forum posts.
The research, conducted by scientists from Penn Engineering, focused on social media platforms like Reddit to identify less-known problems associated with these injections. The findings suggest that there may be a gap between the clinical data and the real-world experiences of patients.
Understanding the Research
The study analyzed user discussions on Reddit to explore whether long-term users of GLP-1 drugs were reporting new concerns. Researchers found that changes to menstrual cycles and sudden shifts in body temperature—such as chills, hot flushes, and fever-like symptoms—may need further investigation.
Sharath Chandra Guntuku, the study’s senior author, noted that while some side effects like nausea are well known, the underreported symptoms come directly from patients. He emphasized that clinicians should pay attention to these reports.
Around four percent of Reddit users in the study reported menstrual irregularities. These can include missed periods, unusually heavy bleeding, or cycles that vary sharply in length. Neil Sehgal, the study’s first author, suggested that the proportion could be even higher in female-only research, indicating a signal worth investigating.
Demographics and Side Effects
The researchers noted that Reddit users are more likely to be male and predominantly based in the United States. Overall, about 44 percent of users analyzed reported at least one side effect, most commonly stomach problems such as pain and nausea. Fatigue was the second most frequently reported complaint.
Other users described chills, feeling unusually cold, hot flushes, and fever-like symptoms. Jena Shaw Tronieri, a senior research investigator at Penn and co-author of the study, explained that these drugs work by engaging the hypothalamus, which regulates various hormones. While this doesn’t necessarily mean the medications cause these symptoms, it suggests that reports of menstrual changes and body temperature fluctuations are worth studying more systematically.
Lyle Ungar, a professor in Computer and Information Science and a co-author on the study, pointed out that clinical trials generally identify the most dangerous side effects but can sometimes miss what symptoms patients are most concerned about. He compared online patient communities to “a neighbourhood grapevine,” where people share experiences that rarely make it into a doctor’s office visit or an official report.
Implications and Future Research
Sehgal emphasized that the researchers could not prove the GLP-1 drugs were “actually causing these symptoms,” but argued the findings deserved further scrutiny. Semaglutide, the active ingredient in these drugs, became available as a weight-loss treatment in the UK in 2018, with around 10.2 million prescriptions issued over the past five years.
Most users are thought to be accessing the drugs privately rather than via the NHS, with use doubling between 2024 and 2025. As more people continue to use these medications, ongoing research and monitoring will be essential to understand their long-term effects and ensure patient safety.
